Moreover, we identified specific alterations in GABAergic CINs and underlying molecular mediators (e.g., MTOR and Kv3.1) that could plausibly contribute to neurocognitive symptoms of TSC. This evidence concerns the gene KCNC1 and tuberous sclerosis.